Conference discussion: Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.

Autor: Wahba, A, Vonk, A, Bidstrup, B
Zdroj: Interactive Cardiovascular and Thoracic Surgery; February 2011, Vol. 12 Issue: 2 p139-140, 2p
Databáze: Supplemental Index